Annual Accounts Payable
$7.97 M
+$1.39 M+21.21%
September 30, 2024
Summary
- As of February 7, 2025, OTLK annual accounts payable is $7.97 million, with the most recent change of +$1.39 million (+21.21%) on September 30, 2024.
- During the last 3 years, OTLK annual accounts payable has risen by +$5.77 million (+262.82%).
- OTLK annual accounts payable is now -31.09% below its all-time high of $11.56 million, reached on September 30, 2014.
Performance
OTLK Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$7.97 M
+$2.42 M+43.52%
September 1, 2024
Summary
- As of February 7, 2025, OTLK quarterly accounts payable is $7.97 million, with the most recent change of +$2.42 million (+43.52%) on September 1, 2024.
- Over the past year, OTLK quarterly accounts payable has increased by +$4.49 million (+128.97%).
- OTLK quarterly accounts payable is now -44.72% below its all-time high of $14.42 million, reached on March 31, 2016.
Performance
OTLK Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
OTLK Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.2% | +129.0% |
| 3 y3 years | +262.8% | +262.8% |
| 5 y5 years | +249.8% | +141.0% |
OTLK Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +262.8% | at high | +221.2% |
| 5 y | 5-year | at high | +262.8% | at high | +262.8% |
| alltime | all time | -31.1% | +262.8% | -44.7% | +262.8% |
Outlook Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $7.97 M(+21.2%) | - |
| Sep 2024 | - | $7.97 M(+43.5%) |
| Jun 2024 | - | $5.55 M(+27.3%) |
| Mar 2024 | - | $4.36 M(+25.4%) |
| Dec 2023 | - | $3.48 M(-47.1%) |
| Sep 2023 | $6.57 M(+88.3%) | $6.57 M(+30.0%) |
| Jun 2023 | - | $5.06 M(+39.7%) |
| Mar 2023 | - | $3.62 M(-13.2%) |
| Dec 2022 | - | $4.17 M(+19.4%) |
| Sep 2022 | $3.49 M(+59.0%) | $3.49 M(+40.7%) |
| Jun 2022 | - | $2.48 M(-40.4%) |
| Mar 2022 | - | $4.16 M(+63.4%) |
| Dec 2021 | - | $2.55 M(+15.9%) |
| Sep 2021 | $2.20 M(-8.3%) | $2.20 M(-17.8%) |
| Jun 2021 | - | $2.67 M(-57.8%) |
| Mar 2021 | - | $6.33 M(+89.9%) |
| Dec 2020 | - | $3.33 M(+39.2%) |
| Sep 2020 | $2.39 M | $2.39 M(-52.2%) |
| Jun 2020 | - | $5.01 M(+51.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $3.31 M(+28.8%) |
| Dec 2019 | - | $2.57 M(+12.7%) |
| Sep 2019 | $2.28 M(-36.9%) | $2.28 M(-23.8%) |
| Jun 2019 | - | $2.99 M(-41.6%) |
| Mar 2019 | - | $5.11 M(+8.9%) |
| Dec 2018 | - | $4.70 M(+30.1%) |
| Sep 2018 | $3.61 M(-67.0%) | $3.61 M(+7.7%) |
| Jun 2018 | - | $3.35 M(-7.1%) |
| Mar 2018 | - | $3.61 M(-0.6%) |
| Dec 2017 | - | $3.63 M(-66.9%) |
| Sep 2017 | $10.95 M(+116.0%) | $10.95 M(-7.1%) |
| Jun 2017 | - | $11.79 M(-3.0%) |
| Mar 2017 | - | $12.15 M(+10.0%) |
| Dec 2016 | - | $11.05 M(+117.9%) |
| Sep 2016 | $5.07 M(-56.1%) | $5.07 M(+11.8%) |
| Jun 2016 | - | $4.53 M(-68.5%) |
| Mar 2016 | - | $14.42 M(+24.1%) |
| Dec 2015 | - | $11.62 M(+0.5%) |
| Sep 2015 | $11.56 M(0.0%) | $11.56 M |
| Sep 2014 | $11.56 M | - |
FAQ
- What is Outlook Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Outlook Therapeutics?
- What is Outlook Therapeutics annual accounts payable year-on-year change?
- What is Outlook Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly accounts payable year-on-year change?
What is Outlook Therapeutics annual accounts payable?
The current annual accounts payable of OTLK is $7.97 M
What is the all time high annual accounts payable for Outlook Therapeutics?
Outlook Therapeutics all-time high annual accounts payable is $11.56 M
What is Outlook Therapeutics annual accounts payable year-on-year change?
Over the past year, OTLK annual accounts payable has changed by +$1.39 M (+21.21%)
What is Outlook Therapeutics quarterly accounts payable?
The current quarterly accounts payable of OTLK is $7.97 M
What is the all time high quarterly accounts payable for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly accounts payable is $14.42 M
What is Outlook Therapeutics quarterly accounts payable year-on-year change?
Over the past year, OTLK quarterly accounts payable has changed by +$4.49 M (+128.97%)